Deimplementing CXR After CVC (DRAUP) in the ICU
Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Nov 17, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The DRAUP study is looking at a new program designed to help doctors and hospitals stop using chest X-rays (CXRs) unnecessarily after placing a central venous catheter (CVC) in patients in the intensive care unit (ICU). This study aims to see if the DRAUP program can effectively change the way healthcare providers think about and use these X-rays, ultimately improving patient care and reducing costs. The researchers will gather information to refine the program for future, larger studies.
If you're an ICU doctor, advanced practice nurse, or a senior resident with experience in placing CVCs, you might be eligible to participate in the DRAUP program. Participants will receive training on how to implement this new approach. However, patients in certain critical conditions, like severe shock or trauma, will not be included in this study. Overall, the trial is focused on improving healthcare practices in the ICU, and your involvement could help shape better care for future patients.
Gender
ALL
Eligibility criteria
- • -Measure the effectiveness and cost effectiveness of DRAUP on discontinuation of CXRs
- Inclusion Criteria for DRAUP training:
- • (1) ICU faculty, fellows, senior residents (post graduate year 3) and advanced practice practitioners
- * ICU inclusion for DRAUP program:
- • Availability of ultrasound machines with archiving capability (DICOM)
- • A minimum of 100 supradiaphragmatic CVC insertions annually in adult patients (age \>18)
- • Capacity to access digital archiving (PICOM)
- * Patient inclusion for DRAUP program:
- • supradiaphragmatic CVC placed
- * Patient exclusion for DRAUP program:
- • severe instability (cardiac arrest, severe shock) where CVC would be used without CXR,
- • level 1 trauma;
- • burn patients with no viable skin surface for imaging
About Washington University School Of Medicine
Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
St Louis, Missouri, United States
Saint Louis, Missouri, United States
Patients applied
Trial Officials
Enyo Ablordeppey, MD MPH
Principal Investigator
Washington University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported